TransCode Therapeutics (RNAZ) Stock Chart & Stock Price History $9.75 +0.72 (+7.97%) (As of 12/4/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends TransCode Therapeutics Stock Price Performance 5 Day Performance+2,701.72%1 Month Performance+1,793.20%3 Month Performance+4,022.62%6 Month Performance+616.91%Year-To-Date Performance+47.91%1 Year Performance+6.91% Receive RNAZ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TransCode Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address “Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad)Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. RNAZ Stock Chart for Wednesday, December, 4, 2024 RNAZ Chart by TradingView TransCode Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/04/2024$0.27$9.75+3,462.29%$9.89$8.15113,012 shs$168.38 million12/03/2024$0.28$0.27-3.32%$0.31$0.251.42 million shs$4.73 million12/02/2024$0.35$0.28-18.65%$0.34$0.271.83 million shs$4.89 million11/29/2024$0.34$0.35+1.43%$0.37$0.33190,131 shs$6.01 million11/28/2024$0.34$0.34$0.38$0.33658,129 shs$5.93 million11/27/2024$0.38$0.34-8.99%$0.38$0.33648,489 shs$5.93 million Get the Latest News and Ratings for RNAZ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TransCode Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/26/2024$0.34$0.38+9.59%$0.46$0.341.45 million shs$6.51 million11/25/2024$0.38$0.34-10.53%$0.38$0.33933,185 shs$5.94 million11/22/2024$0.37$0.38+3.06%$0.39$0.36267,237 shs$6.64 million11/21/2024$0.34$0.37+10.98%$0.39$0.33510,251 shs$6.44 million11/20/2024$0.33$0.34+2.50%$0.34$0.33203,695 shs$5.81 million11/19/2024$0.33$0.33-0.61%$0.34$0.32114,273 shs$5.67 million11/18/2024$0.34$0.33-2.86%$0.35$0.33217,903 shs$5.70 million11/15/2024$0.35$0.34-2.92%$0.37$0.31252,839 shs$5.87 million11/14/2024$0.36$0.35-3.95%$0.38$0.34220,964 shs$6.04 million11/13/2024$0.39$0.36-6.18%$0.39$0.36398,044 shs$6.29 million11/12/2024$0.40$0.39-2.85%$0.40$0.31866,411 shs$6.70 million11/11/2024$0.45$0.40-12.08%$0.46$0.39840,329 shs$6.90 million11/08/2024$0.47$0.45-3.28%$0.49$0.45219,492 shs$7.85 million11/07/2024$0.47$0.47+0.21%$0.47$0.45304,557 shs$8.12 million11/06/2024$0.51$0.47-7.46%$0.51$0.46555,750 shs$8.10 million11/05/2024$0.52$0.51-1.59%$0.53$0.48415,732 shs$8.75 million11/04/2024$0.48$0.52+7.29%$0.55$0.49571,232 shs$8.89 million Related Companies Cyclo Therapeutics Stock Chart MEI Pharma Stock Chart BioXcel Therapeutics Stock Chart ProPhase Labs Stock Chart Marinus Pharmaceuticals Stock Chart Mannatech Stock Chart Aprea Therapeutics Stock Chart Cognition Therapeutics Stock Chart Synlogic Stock Chart NRx Pharmaceuticals Stock Chart Receive RNAZ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TransCode Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RNAZ) was last updated on 12/4/2024 by MarketBeat.com Staff From Our PartnersLock in this share price before 12/5When the team that built Zillow into a $16B real estate leader launches a new company, it’s worth paying atten...Pacaso | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredStrange: Why is Amazon suddenly yielding 39.70%?Something big is happening with Amazon stock… While most investors collect ZERO dividends from Amazon… A...Investors Alley | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredWhat will be the biggest trades of 2025?From Government Secrets to Triple-Digit Wins The 3 Profit Structures You Need to Know - REGISTER HERE.10 Minute Trades | SponsoredThe 2024 TECH RESETAre we on the edge of the biggest ‘TECH RESET’ in decades?InvestorPlace | SponsoredMeet the NYSE traded company behind a potentially blockbuster antiviral drugThis public company’s one lead drug alone, NV-387, potentially addresses a $2.5 to $4.3 billion market Imag...Smallcaps Daily | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TransCode Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TransCode Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
